Expression of pS2 is driven by a complex promoter containing a promoter/enhancer region responsive to estrogens, EGF, a phorbol ester tumor promoter, c-Ha-ras oncoprotein, and c-jun protein [33]. Here, JUN is linked to neoplasm.